These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


152 related items for PubMed ID: 460538

  • 21. A defect in catecholamine neurons in patients with prolactin-secreting pituitary adenoma.
    Van Loon GR.
    Lancet; 1978 Oct 21; 2(8095):868-71. PubMed ID: 81414
    [Abstract] [Full Text] [Related]

  • 22. Dopamine and sympathoadrenal activity in man.
    Mannelli M, Lazzeri C, Ianni L, La Villa G, Pupilli C, Bellini F, Serio M, Franchi F.
    Clin Exp Hypertens; 1997 Oct 21; 19(1-2):163-79. PubMed ID: 9028644
    [Abstract] [Full Text] [Related]

  • 23. Dopaminergic effects on kidney function and responsiveness of aldosterone, plasma renin activity, prolactin, catecholamines, and blood pressure to stimulation in patients with prolactinoma. Comparison of the efficacy of pergolide and bromocriptine therapy.
    Jungmann E, Haak T, Althoff PH, Fassbinder W, Schöffling K.
    Arzneimittelforschung; 1988 Feb 21; 38(2):296-300. PubMed ID: 3285838
    [Abstract] [Full Text] [Related]

  • 24. Abnormal catecholamine mechanisms in hypothalamic-pituitary disorders.
    Van Loon GR.
    Metabolism; 1980 Nov 21; 29(11 Suppl 1):1198-202. PubMed ID: 7432178
    [Abstract] [Full Text] [Related]

  • 25. Bromocriptine inhibits norepinephrine release.
    Ziegler MG, Lake CR, Williams AC, Teychenne PF, Shoulson I, Steinsland O.
    Clin Pharmacol Ther; 1979 Feb 21; 25(2):137-42. PubMed ID: 759066
    [Abstract] [Full Text] [Related]

  • 26. A study on human adrenal secretion. Measurement of epinephrine, norepinephrine, dopamine and cortisol in peripheral and adrenal venous blood under surgical stress.
    Mannelli M, Gheri RG, Selli C, Turini D, Pampanini A, Giusti G, Serio M.
    J Endocrinol Invest; 1982 Feb 21; 5(2):91-5. PubMed ID: 7096922
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Orthostatic hypotension: a posture-induced hyperdopaminergic state.
    Kuchel O, Buu NT, Hamet P, Larochelle P, Gutkowska J, Schiffrin EL, Bourque M, Genest J.
    Am J Med Sci; 1985 Jan 21; 289(1):3-11. PubMed ID: 3881951
    [Abstract] [Full Text] [Related]

  • 30. Neuronal and postjunctional components in the blood pressure effects of dopamine and bromocriptine in rabbits.
    Ensinger H, Majewski H, Hedler L, Starke K.
    J Pharmacol Exp Ther; 1985 Sep 21; 234(3):681-90. PubMed ID: 2993590
    [Abstract] [Full Text] [Related]

  • 31. Bromocriptine-induced inhibition of plasma dopamine, noradrenaline and adrenaline responses to LH-RF.
    Van Loon GR.
    Nature; 1978 Sep 28; 275(5678):331-2. PubMed ID: 357990
    [No Abstract] [Full Text] [Related]

  • 32. Catecholamine, renin, aldosterone, and arginine vasopressin responses to lower body negative pressure and tilt in normal humans: effects of bromocriptine.
    Mohanty PK, Sowers JR, Beck FW, Godschalk MF, Schmitt J, Newton M, McNamara C, Verbalis JG, McClanahan M.
    J Cardiovasc Pharmacol; 1985 Sep 28; 7(6):1040-7. PubMed ID: 2418286
    [Abstract] [Full Text] [Related]

  • 33. Plasma dopamine: regulation and significance.
    Van Loon GR.
    Fed Proc; 1983 Oct 28; 42(13):3012-8. PubMed ID: 6413258
    [Abstract] [Full Text] [Related]

  • 34. Blood pressure, plasma and pituitary prolactin responses to bromocriptine in New Zealand genetically hypertensive and normotensive rats.
    Tan BK, Hutchinson JS.
    Clin Exp Pharmacol Physiol; 1989 Jan 28; 16(1):13-8. PubMed ID: 2706805
    [Abstract] [Full Text] [Related]

  • 35. Mechanism of the depressor effect of bromocriptine in the spontaneously hypertensive rat.
    Nagahama S, Chen YF, Oparil S.
    J Pharmacol Exp Ther; 1984 Feb 28; 228(2):370-5. PubMed ID: 6363675
    [Abstract] [Full Text] [Related]

  • 36. Correlations of catecholamine release in the medial preoptic area with proestrous surges of luteinizing hormone and prolactin: effects of aging.
    Mohankumar PS, Thyagarajan S, Quadri SK.
    Endocrinology; 1994 Jul 28; 135(1):119-26. PubMed ID: 8013343
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Bromocriptine treatment of microprolactinomas: evidence of stable prolactin decrease after drug withdrawal.
    Moriondo P, Travaglini P, Nissim M, Conti A, Faglia G.
    J Clin Endocrinol Metab; 1985 Apr 28; 60(4):764-72. PubMed ID: 3919052
    [Abstract] [Full Text] [Related]

  • 40. The effects of dopamine agonists on human cardiovascular and sympathetic nervous systems.
    Ziegler MG, Kennedy B, Holland OB, Murphy D, Lake CR.
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr 28; 23(4):175-9. PubMed ID: 3158615
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.